Monkeypox Antivirals Under CDC Lockdown

August 22, 2024

https://popularrationalism.substack.com/p/cdc-has-monkeypox-antivirals-under?

CDC Has Monkeypox Antivirals Under Lockdown

The STOMP trial or CDC’s “expanded access protocols” are the only way to get treatments studied so far to patients. So far, one natural compound has been studied.

 
James Lyons-Weiler
Aug 22, 2024

In an unusual move, the CDC is holding a monopoly on access to drugs that might be useful in treating a contagious virus. Here, we explore standard-of-care options for treating monkeypox.

Physicians in the field have found that care primarily focuses on alleviating symptoms and preventing complications, as no specific antiviral treatment has been approved specifically for monkeypox.

Potential (proposed) guidelines for managing the condition:

1. Symptomatic Treatment:

– Pain and Fever Management: Over-the-counter pain relievers such as ibuprofen or acetaminophen can help manage pain and fever.

– Hydration: Ensuring adequate fluid intake to prevent dehydration is crucial.

– Skin Care: Keep the skin lesions clean and dry. Calamine lotion or antihistamines might be used to alleviate itching.

2. Isolation and Prevention:

Isolation: Patients should be isolated to prevent the spread of the virus, especially when they are symptomatic and have active lesions.

– Hygiene: Regular handwashing and disinfecting surfaces can help reduce transmission.

3. Antiviral Treatments:

Tecovirimat (TPOXX) is an antiviral medication approved for the treatment of smallpox. Due to its activity against orthopoxviruses, it is sometimes used under compassionate use or in clinical trials for monkeypox.

Cidofovir and Brincidofovir are antiviral drugs sometimes used to treat severe orthopoxvirus infections. Their use for monkeypox is not well established, but it is generally considered when other options are unavailable.

4. Supportive Care:

– Monitoring for Complications: Patients should be monitored for potential complications, such as bacterial infections of skin lesions, pneumonia, or encephalitis, especially in immunocompromised individuals.

– Hospitalization: Severe cases may require hospitalization for supportive care and treatment of complications.

5. Counseling and Mental Health Support:

– Psychological Support: Patients with monkeypox may require psychological support due to the stigma and isolation associated with the disease.  (See link for article)

_______________

**Comment**

The CDC monopolizing testing and treatment is its MO:

Category:

Activism, Treatment, Viruses

Comments Off on Monkeypox Antivirals Under CDC Lockdown

Similarities Between ‘Spike Protein’ and Synthetic Anthrax Toxin

https://sashalatypova.substack.com/p/some-similarities-between-spike-protein

Similarities between “spike protein” and synthetic anthrax toxin.

Real bioweapons are not viruses but chemical weapons.

Sasha Latypova
Aug 21, 2024

PREP Act declarations should be read as announcements of use of certain types of chemical-biological weapons of mass destruction. As my readers know, covid PREP Act declaration is currently active until Dec 31, 2024, but it will be for sure extended thereafter. Marburg and Ebola declarations are active until at least Dec 31, 2028.

There are several non-covid PREP Act declarations currently active: These declarations are for influenza, zika, insecticides/nerve agents, anthrax and botulism toxin. They were updated/re-issued on Dec 23, 2022, however for all of these agents, the original declarations had been issued many years ago, starting around 2008.

Both, manufacturers and users would have liability immunity.

Users of the first countermeasures being the DoD agents who did/do the dispersing of the aerosol, water-borne, food-borne poisons.

Users of the second countermeasures being the pharmacists, nurses, doctors, midwives, etc who did/do the injections falsely advertised as treatments for the first set of countermeasures.

This prompted me into looking at the literature and trying to see any patterns that would indicate that some of the toxins being covered under PREP Act declarations can be used to simulate “viral pandemics”.

I will briefly address the nerve agents first and then write more about interesting parallels between anthrax toxin and so-called “spike protein” purported to be the agent of both, covid illness and covid vaccine injury.  (See link for article)

______________

SUMMARY:

  • Latypova believes poisoning via chemical agents is a very plausible explanation for many historical ‘pandemics’ and ‘epidemics,’ however, she doesn’t believe these agents were used for simulating the COVID outbreak.
  • “PREP Act declarations are a key part of the “pandemic preparedness” racket run by the military-industrial mafia (International Medical Countermeasures Consortium) and propagandized on all sides of freedom by characters like Robert Malone.”
  • The biodefense mafia operates on word confusion.
  • Naturally occurring anthrax is a soil bacterium that exists as a spore but is not typically transmissible or dangerous.
  • In 10 years of targeted effort there’s been about 68 patients with anthrax found in China in a country of 1.3 billion and nobody died.
  • It is treatable with antibiotics and there is no need for vaccination.
  • The anthrax vaccine manufactured by Emergent is much more poisonous than naturally occurring anthrax.
  • What is made in a lab is a synthetic chemical toxin allegedly resembling a small part of b. anthracis.
  • Synthetic chemicals do not reproduce or spread or ‘leak’ by themselves. The best way to produce mass illness is by injection under the pretense of ‘vaccination.’
  • This is exactly what happened to Gulf War soldiers through anthrax vaccination.
  • Synthetic anthrax is a chemical weapon (toxin) that can be assembled from ‘legal’ components.
  • Animal studies showed that certain components of this synthetic anthrax are lethal above a certain dosage, other components produce a ‘mild clinical disease.’
    • The monkey study conducted at the University of New Mexico in 2014 used both synthetic and allegedly natural anthrax.  The ‘natural’ Ames strain (A.Br.Ames lineage) came from US Army, Ft. Detrick which originates predominantly in China.
  • Symptoms were: decreased appetite and activity level, a mild, dry cough, elevated C-reactive protein and neutrophil counts indicating an inflammatory response and low-level transient bacteremia.
  • Decreased appetite and rapid weight loss are the most characteristic of COVID poisoning.  These same symptoms were reported in rats in both Pfizer’s and Moderna’s vax studies.
  • There are similarities between the COVID spike protein and the anthrax toxin and both include the furin cleavage site.
  • Dr. Lee Merritt has been outspoken about COVID being a type of contact poison or toxin.  She also speaks prolifically about parasites.
  • Hopefully when people are aware that chemical poisoning can mimic and fake “infectious outbreaks” they will be less likely to fall for propaganda of “lab created viruses.”  (See link for article)

Category:

Activism, vaccines, Viruses

Comments Off on Similarities Between ‘Spike Protein’ and Synthetic Anthrax Toxin

The Thorny Question of Persistent Lyme, Or IACI

https://www.lymedisease.org/nasem-takes-on-lyme-iaci/

The thorny question of persistent Lyme, or rather “Lyme IACI”

July 18, 2024

By Dorothy Kupcha Leland

The National Academies of Sciences, Engineering, and Medicine (known collectively as NASEM) are private, nonprofit institutions that examine challenging issues and offer advice to the nation.

Academy members are elected based on their outstanding achievements and contributions to their fields. They are considered the cream of the cream.

NASEM works by convening committees of experts from various fields to study specific topics. Sometimes, these committees organize workshops to bring together experts, policymakers, and the public to share knowledge and explore solutions.

That’s what happened July 11, in Washington DC. A NASEM committee held a workshop examining the question of what they called “Lyme infection-associated chronic illness”—or “Lyme IACI.” (Pronounced “Lyme eye-ACK-ee” by most participants, it doesn’t exactly roll off the tongue, does it?)

Apparently, Lyme IACI is the label the committee landed on to avoid the polarizing effects of such terms as “chronic Lyme” or “post-treatment Lyme disease syndrome.”

Based on input from this public workshop as well as a review of medical literature, the committee will develop a report of its findings. This document will put forth recommendations for how to bring about better treatments for people with Lyme IACI.

You may remember that NASEM held a groundbreaking workshop last year that focused on the commonalities of several “long haul” diseases—long COVID, persistent Lyme disease, multiple sclerosis and ME/CFS (chronic fatigue). Read more about last year’s event here: “Words matter.” A new way of thinking about long-haul diseases.

The 2024 conference continued in that vein, but this time focused only on Lyme IACI. The event was significant on several fronts.

Why this matters

For starters, you had important scientists exploring the question of why some people with Lyme disease continue to have symptoms despite treatment. This major change comes after decades of “Lyme denialism,” when medical professionals, health officials, researchers, the NIH, and the CDC, all told us that what we call “chronic Lyme” didn’t even exist. So, just the fact that you have a NASEM committee considering the issue is a huge step forward.

Furthermore, the Lyme community actively participated in the event.

Retired US Air Force Col. Nicole Malachowski—a prominent advocate for those with tick-borne disease—served on the workshop’s planning committee.

Rhisa Parera

Rhisa Parera, the writer/director/producer of the Lyme film “Your Labs are Normal,” delivered a keynote address on the patient perspective.

Read what she told the panel: Patient tells scientists “Lyme is a literal emergency. Help us.”

The committee lined up an impressive array of researchers from prominent academic centers to shed light on the following questions:

  • Describe the current state of Lyme IACI research for treatments and diagnostics to clarify barriers in development of new, effective therapeutic interventions;
  • Explore recent advancements from other biomedical research fields with the potential to address these barriers by catalyzing scientific breakthroughs or translation of discoveries to treatments;
  • Understand patient-defined priorities for research and discuss potential opportunities for engaging this perspective in developing a biomedical research agenda; and
  • Discuss research strategies and infrastructure that could facilitate the application of innovations from other fields into the Lyme IACI research context.

See the list of speakers here.

Patient priorities

LymeDisease.org CEO Lorraine Johnson, principal investigator of the MyLymeData project, spoke on a panel about patient-defined priorities for research.

Lorraine Johnson, Principal Investigator of MyLymeData

She emphasized the importance of outcomes that patients themselves care about—namely, getting their health back and being able to return to work and other activities.

But that’s often not the way clinical trials are structured. For example, many are geared to evaluating something called the SF-36 score.

“However, a change in the SF-36 score is not inherently meaningful or important to patients,” Lorraine noted. “This is obvious on its face. If you ask any patient what they want in healthcare – none of them will say, ‘I want to improve my SF-36 score.’”

Videos from the workshop should be available soon. When they are, I strongly recommend you watch Lorraine’s presentation. I think you’ll find it riveting.

More on this event still to come. Stay tuned.

TOUCHED BY LYME is written by Dorothy Kupcha Leland, President of LymeDisease.org. She is co-author of Finding Resilience: A Teen’s Journey Through Lyme Disease and of When Your Child Has Lyme Disease: A Parent’s Survival Guide. Contact her at dleland@lymedisease.org.

_______________

**Comment**

I have a far dimmer view of this gathering of the ‘cream of the cream.’

Until Lyme literate doctors and independent researchers are equally represented within these groups, I hold little hope for much change.

First off, this group proudly deploys the climate, health, and equity  propaganda pushed by globalists.

The sponsors of the organization are none other than:

AstraZeneca
Burroughs Wellcome Fund
Grantham Foundation
JPB Foundation​
McCall MacBain Foundation
Rockefeller Foundation

Go here for more.

Are you getting this yet?

Now, this elitist group with Big Pharma ties has developed yet another acronym instead of just stating what it is: a complex, polymorphic, polymicrobial, chronic infection that has destroyed lives for over 40 years and shows no sign of slowing down.

The fact this group will “not make recommendations on specific approaches to diagnosis and treatment when it issues a report in early 2025, but will instead present ‘consensus findings’ on treatment for chronic illness associated with Lyme disease, including recommendations for advancing treatment,” does not comfort me much.

I can tell you right now what ‘consensus’ states since Lyme literate doctors have been persecuted for stepping outside this rigidly defined box.  It will simply regurgitate 40 year old dogma created at Dearborn, MI when they took the most sensitive band for borrelia out of testing so it wouldn’t conflict with the highly lucrative, but deadly Lymerix vaccine.

Nothing’s changed – but has only become more entrenched.  

Category:

Activism, Lyme

Comments Off on The Thorny Question of Persistent Lyme, Or IACI

Aussie, German, Korean, Japanese, & Scandinavian Studies on COVID Shots: Excess Deaths, Organ Damage, Auto-Immunity, Myocarditis & Pericarditis, & Deadly Batches

August 21, 2024

https://childrenshealthdefense.org/defender/covid-vaccine-excess-deaths-australia/

Australian Researcher Finds Link Between COVID Vaccines and Excess Deaths

The number of excess deaths in Australia was positively correlated with the number of COVID-19 booster vaccinations, according to a new peer-reviewed study. However, critics cautioned that the study’s methods were too simplistic and that its results could be misleading.

by Suzanne Burdick, Ph.D.
AUGUST 15, 2024

Article excerpts:

Denis Rancourt, Ph.D., lead author of a recent study examining excess mortality in 125 countries, cautioned against drawing conclusions from Allen’s analysis. He told The Defender:

“This type of correlation analysis between bulk measures of excess mortality and vaccine doses administered has many caveats, pitfalls and known confounding factors.

“It should never be used as a stand-alone result, as was done here. On its own, it has a high likelihood of being misleading, and it does not imply any meaningful relation.”

Rancourt said that even if a relationship exists between COVID-19 vaccination and excess death, there are better ways of statistically showing it.

“Scientists should avoid being right for the wrong reasons,” Rancourt said. “A better approach is to look for temporal associations, which has been done in some detail for Australia.”  (See link for article)

Also, please see:  https://madisonarealymesupportgroup.com/2024/08/15/study-of-125-countries-meta-analysis-on-covid-shots/  The shots are worthless but dangerous.

______________

https://slaynews.com/news/top-study-links-covid-shots-surge-organ-damage-among-children/

Top Study Links Covid Shots to Surge in Organ Damage among Children

Frank Bergman

A team of leading scientific researchers in Germany has just issued a warning to the public after finding direct links between Covid mRNA shots and vital organ damage among children.

Specifically, the researchers found that Pfizer’s mRNA injection is responsible for skyrocketing cases of Immunoglobulin G4-related disease (IgG4-RD) in children aged 5 to 11 years old.

IgG4-RD is a condition that causes inflammation inside the body and damages internal organs, according to Oxford University.

It can affect many different organs, meaning people can have wide-ranging symptoms.

The pancreas is most commonly affected, followed by the bile ducts in the liver, the salivary glands, and the kidneys.  (See link for article)

_______________

https://petermcculloughmd.substack.com/p/large-korean-study-recommends-monitoring

Large Korean Study Recommends Monitoring mRNA Vaccinated Patients for Auto-immunity

Modest Risks Identified, but Cumulative Effects with Repeated Boosters are Concerning

 
JUL 27, 2024

By Peter A. McCullough, MD, MPH

Article excerpts:

There is great concern that with continued dosing of mRNA COVID-19 vaccines, the human body is forced to produce not only the foreign and potentially lethal Wuhan Spike protein, but probably about a dozen additional frameshifted proteins as shown by Boros and colleagues. Invariably these peptides induce an immune attack against the human body as they are expressed on cell surfaces and in some cases like Spike protein, trimerize and are circulatory in blood for months after injection.

Now a large study from Korea by Jung et al, suggests there are increased risks for some autoimmune illnesses after at least two mRNA shots, but not nearly as high as the established dangers of vaccine myo-pericarditis or Guillain-Barre Syndrome.  (See link for article)

https://www.jiac-j.com/article/S1341-321X(24)00209-5/abstract

Japanese Study: COVID mRNA Shots “Significantly Associated” With Myocarditis & Pericarditis

Abstract

Background

The association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines and myocarditis/pericarditis in the Japanese population has not been systematically investigated. This study was aimed at clarifying the association between SARS-CoV-2 mRNA vaccines (BNT162b2 and mRNA-1273) and myocarditis/pericarditis as well as influencing factors by using the Japanese Adverse Drug Event Report database.

Methods

Reporting odds ratios (RORs) and 95 % confidence intervals (95 % CIs) for the association between the vaccines and myocarditis/pericarditis were calculated using data from the database (April 2004–December 2023). Age, sex, onset time, and outcomes in symptomatic patients were evaluated.

Results

The total number of reports was 880,999 (myocarditis: 1846; pericarditis: 761). The adverse events associated with the vaccines included myocarditis (919 cases) and pericarditis (321 cases), with the ROR [95 % CIs] being significant for both (myocarditis: 30.51 [27.82–33.45], pericarditis: 21.99 [19.03–25.40]). Furthermore, the ROR [95 % CIs] of BNT162b2 and mRNA-1273 were 15.64 [14.15–17.28] and 54.23 [48.13–61.10], respectively, for myocarditis, and 15.78 [13.52–18.42] and 27.03 [21.58–33.87], respectively, for pericarditis. Furthermore, most cases were ≤30 years or male. The period from vaccination to onset was ≤8 days, corresponding to early failure type based on analysis using the Weibull distribution. Outcomes were recovery or remission for most cases; however, they were severe or caused death in some cases.

Conclusion

In the Japanese population, SARS-CoV-2 mRNA vaccination was significantly associated with the onset of myocarditis/pericarditis. The influencing factors included age of ≤30 years and male. Furthermore, although most adverse events occurred early after vaccination, overall outcomes were good.
 

Scandinavian Study Confirms Pfizer Pushed ‘BAD BATCHES’ of Covid Shots onto Public

by Vibeke Manniche1, Max Schmeling2, Jonathan D. Gilthorpe3 and Peter Riis Hansen4,5,*
 
Medicina 2024, 60(8), 1343; https://doi.org/10.3390/medicina60081343
Submission received: 17 July 2024 / Revised: 13 August 2024 / Accepted: 14 August 2024 / Published: 19 August 2024

Abstract

Background and Objective: An unexpected batch-dependent safety signal for the BNT162b2 mRNA COVID-19 vaccine was recently identified in a nationwide study from Denmark, but the generalizability of this finding is unknown. Therefore, we compared batch-dependent rates of suspected adverse events (SAEs) reported to national authorities in Denmark and Sweden. 
 
Materials and Methods: SAE and vaccine batch data were received from national authorities in Denmark and Sweden, and analyses of heterogeneity in the relationship between numbers of vaccine doses and SAEs per batch were performed, along with comparison of SAE rates and severities for batches that were shared between the two countries. 
 
Results: Significant batch-dependent heterogeneity was found in the number of SAEs per 1000 doses for both countries, with batches associated with high SAE rates detected in the early phase of the vaccination campaign and positive correlations observed between the two countries for the severity of SAEs from vaccine batches that they shared. Mild SAEs predominated in the batches used in the early part of the vaccination roll-out, where markedly higher SAE rates per 1000 doses in Denmark for the batches that were shared between the two countries suggested that a large proportion of these SAEs were under-reported in Sweden. 
 
Conclusions: The batch-dependent safety signal observed in Denmark and now confirmed in Sweden suggests that early commercial batches of BNT162b2 may have differed from those used later on, and these preliminary and hypothesis-generating results warrant further study.
 
They simply couldn’t allow too many people to be maimed and killed early on.  People would have noticed.
 
For more:

Category:

Activism, research, vaccines, Viruses

Comments Off on Aussie, German, Korean, Japanese, & Scandinavian Studies on COVID Shots: Excess Deaths, Organ Damage, Auto-Immunity, Myocarditis & Pericarditis, & Deadly Batches

Elucidating Host-Microbe Interactions to Address Vector-Borne Diseases

https://medicine.yale.edu/internal-medicine/infdis/news-article/elucidating-host-microbe-interactions-to-address-vector-borne-diseases/

Elucidating Host-microbe Interactions to Address Vector-borne Diseases

July 08, 2024
by Serena Crawford
Article Excerpts:
In a new study, Yale researchers identified the targets in the human body to which pathogens transmitted by mosquitoes, ticks, and other vectors bind. Their findings, they say, could help address the rising threat of vector-borne diseases, a leading cause of death worldwide.

The study was published in Cell.

“We wanted to better understand the precise mechanisms by which pathogens interact with humans to infect the host and cause disease,” said first author Thomas Hart, PhD, postdoctoral associate at Yale School of Medicine (YSM). “To do so, we tested for interactions between thousands of human proteins and dozens of microbial pathogens, then examined the importance of those identified,” he said.

Pathogens must interact with host molecules, namely host proteins, to infect a host, evade the immune system, and cause symptoms, Hart explained.

One surprising finding was that Borrelia burgdorferi, which causes Lyme disease, appears to interact with epidermal growth factor (EGF), said corresponding author Erol Fikrig, MD, Waldemar Von Zedtwitz Professor of Medicine (Infectious Diseases) and professor of microbial pathogenesis at YSM; and professor of epidemiology (microbial diseases) at the Yale School of Public Health. “Why Borrelia interacts with EGF and what that does for Borrelia pathogenesis is not yet known, and that could have implications for Lyme disease,” he said.
Many of the host-microbe interactions uncovered were unpredictable and unexpected, revealing a suite of novel host-pathogen interactions that can potentially be leveraged to create new classes of anti-infectives that target unique and previously unknown host-microbe interaction nodes, Palm added.  (See link for article)

Category:

Lyme, research

Comments Off on Elucidating Host-Microbe Interactions to Address Vector-Borne Diseases